arrow_back Trending Legislation
Share share

Reauthorization of the Stem Cell Therapeutic and Research Act of 2005

The bill extends the C.W. Bill Young Cell Transplantation Program and the cord blood inventory through 2031. It also increases funding for the program to $33,009,000 annually for fiscal years 2027 through 2031.
Key points
Increases annual funding for the cell transplantation program to $33,009,000 for fiscal years 2027-2031.
Extends the cord blood inventory program through 2031.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Print number: S 4109
Sponsor: Sen. Reed, Jack [D-RI]
Process start date: 2026-03-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3.1-pro-preview
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Reauthorization of the Stem Cell Therapeutic and Research Act of 2005

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 4109.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2026-03-17.

What are the main provisions?

Key points include:

  • Increases annual funding for the cell transplantation program to $33,009,000 for fiscal years 2027-2031.
  • Extends the cord blood inventory program through 2031.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Reed, Jack [D-RI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-03-27.

Analysis and Potential Impact of S 4109

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health